Novel Polymeric Lotion Formulation of Once-Daily Tazarotene (0.045%) for Moderate-to-Severe Acne: Pooled Phase 3 Analysis

March 2020 | Volume 19 | Issue 3 | Original Article | 272 | Copyright © March 2020


Published online March 1, 2020

Emil A. Tanghetti MD,a William Philip Werschler MD,b Edward Lain MD MBA,c Eric Guenin PharmD PhD MPH,d Susan Harris MS,e Anya Loncaric MS,e Radhakrishnan Pillai PhDe

aCenter for Dermatology and Laser Surgery, Sacramento, CA bUniversity of Washington, School of Medicine, Seattle, WA cAustin Institute for Clinical Research, Austin, TX dOrtho Dermatologics, Bridgewater, NJ eBausch Health US, LLC, Petaluma, CA